Abivax Sa ADR (ABVX) Stock Price, Quote & News

Company Profile

ABIVAX Société Anonyme, a clinical-stage biotechnology company, develops therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod, which is in Phase 3 clinical development for the treatment of moderately to severely active UC, as well as Phase 2b clinical trials for Crohn's disease. The company was incorporated in 2013 and is headquartered in Paris, France.

Industry: Biotechnology

Sector: Healthcare

Phone: 33 1 53 83 09 63

Website: www.abivax.com

Address:

7-11 Boulevard Haussmann, Paris, France

Razgooz May. 8 at 11:16 PM

$ABVX monday buyout

0 · Reply

Jblack500 May. 8 at 3:59 PM

$ANIP $GILD $ELAN $ARWR $ABVX who bought the dip..I know I did...current pt is near 110 and will see pt increases on this q and guidance

0 · Reply

SayItToMeSantos May. 8 at 2:58 PM

$SLS Study the $ABVX chart of summer 2025. That's what SLS will do this year. 🤞 All the pieces getting put in place while we wait. Super

0 · Reply

Jblack500 May. 8 at 1:55 PM

$ANIP $GILD $ELAN $ARWR $ABVX anip pullback on these earnings is a gift and should be bought

0 · Reply

Jblack500 May. 8 at 11:59 AM

$ANIP $ABVX $ARWR $GILD $ELAN anip earnings were excellent

0 · Reply

Longi11 May. 8 at 10:22 AM

$ABVX THEY ARE ACQUIRED

2 · Reply

StockProph3t May. 7 at 11:09 PM

$ABVX MDG make retail happy

0 · Reply

CrispDry May. 7 at 5:11 AM

$ABVX anxiety is killing me

1 · Reply

Jblack500 May. 6 at 6:38 PM

@MaverikIT @No_Face_character @cynicaloptimist @IsabellaDC @BustaCapital @WAJeff $ELAN $ABVX $GILD $ARWR $ANIP elan above channel with volume on er. Abvx been quietly moving up. Arwr wants to break out on er tomorrow. Gild er tomorrow bottomed 128. Anip er Friday, great yoy growth and smart move into more rare disease/specialty offerings

1 · Reply

Razgooz May. 6 at 4:10 PM

$ABVX through technicals adding

0 · Reply

Abivax Repurchases Royalty Certificates And Prices $45M ADS Offering To Strengthen Balance Sheet

Tue, 05 May 2026 02:00:00 -0400 - 3 days ago

Abivax Announces Repurchase of Royalty Certificates and Pricing of $45M (€38.5M) Offering of American Depositary Shares

2026-04-28T14:50:09.000Z - 10 days ago

Abivax call volume above normal and directionally bullish

Apr 22, 2026, 4:05 PM EDT - 16 days ago

Abivax to Present Data on Obefazimod at Digestive Disease Week®

ABVX

Apr 20, 2026, 4:05 PM EDT - 18 days ago

Abivax Annual Ordinary and Extraordinary General Meeting of May 11, 2026 Availability of the Preparatory Documents

ABVX

2026-04-09T09:15:22.000Z - 4 weeks ago

Abivax price target raised to EUR 120 from EUR 88 at Oddo BHF

Tue, 07 Apr 2026 15:00:00 -0400 - 4 weeks ago

This Beaten-Down Drug Stock Is Down Over 10% -- Is It Finally a Buy?

2026-04-01T20:21:24.000Z - 5 weeks ago

Abivax appoints Michael Nesrallah as chief commercial officer

TAK

Apr 1, 2026, 4:05 PM EDT - 5 weeks ago

Abivax Publishes Financial Reports with the French and U.S. Securities Regulatory Agencies

ABVX

Thu, 26 Mar 2026 17:30:00 -0400 - 6 weeks ago

2 Healthcare Stocks That Could Soar Over the Next 5 Years

Mar 24, 2026, 1:53 PM EDT - 6 weeks ago

Abivax CEO Downplays Sale Talk, Eyes Capital Raise As Key Trial Data Readout Nears

ABVX

Mar 24, 2026, 11:42 AM EDT - 6 weeks ago

Abivax in no rush for a deal, confident key June trial data can secure better terms for partnerships, CEO tells CNBC

ABVX

2026-03-24T09:30:12.000Z - 6 weeks ago

Abivax price target raised to $148 from $142 at Barclays

2026-03-23T17:06:03.000Z - 6 weeks ago

– Abivax SA American Depositary Shares options imply 8.3% move in share price post-earnings

Fri, 20 Mar 2026 05:34:00 -0400 - 7 weeks ago

2 Healthcare Stocks to Buy Before They Get Bought Out

2026-03-16T00:15:14.000Z - 7 weeks ago

Abivax initiated with a Buy at Jefferies

Mar 12, 2026, 10:33 AM EDT - 2 months ago

Abivax spokesperson denies takeover rumors reported by French media

ABVX

2026-03-12T14:10:32.000Z - 2 months ago

Abivax says ‘we deny the rumors’ to Bloomberg after takeover report

AZN

Mar 12, 2026, 6:46 AM EDT - 2 months ago

Eli Lilly Could Rejoin Abivax Bidding If AstraZeneca Misses Deadline

ABVX LLY

2026-03-12T09:51:46.000Z - 2 months ago

Abivax jumps 15% to $129.11 after report of exclusivity with AstraZeneca

AZN

2026-03-12T09:51:37.000Z - 2 months ago

AstraZeneca granted exclusive period by Abivax for buyout, La Lettre reports

AZN

Tue, 10 Mar 2026 16:00:00 -0400 - 2 months ago

Billionaire Steve Cohen Owns Shares of This Stock That Has Soared 1,600% in The Past Year

Fri, 27 Feb 2026 14:45:00 -0500 - 2 months ago

2 Reasons Abivax Stock Could 10X by 2036

2026-02-24T11:52:54.000Z - 2 months ago

Abivax initiated with an Underperform at Wedbush

2026-02-24T11:51:55.000Z - 2 months ago

Wedbush initiates Abivax with an Underperform, urges caution

2026-02-24T11:45:15.000Z - 2 months ago

Abivax initiated with a Neutral at Wedbush

2026-02-23T16:02:44.000Z - 2 months ago

Magnifique! U.S. Chess Champion’s Healthiest 2026 Move – French Biotech Abivax (ABVX)

LLY

Feb 21, 2026, 6:00 AM EST - 2 months ago

Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease at ECCO 2026

ABVX

Tue, 10 Feb 2026 20:11:00 -0500 - 3 months ago

Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon.

Fri, 30 Jan 2026 15:30:00 -0500 - 3 months ago

Better Long-Term Buy: This Emerging Player or the Industry Leader?

Jan 20, 2026, 6:01 AM EST - 3 months ago

Abivax CEO dismisses 'noise' around rumored Eli Lilly bid

ABVX LLY

Mon, 19 Jan 2026 15:45:00 -0500 - 3 months ago

Prediction: This Healthcare Stock Could Soar by 72% in 2026

Jan 12, 2026, 9:49 AM EST - 4 months ago

France has had no request for investment approval in biotech Abivax - official

ABVX LLY

Jan 12, 2026, 9:32 AM EST - 4 months ago

Abivax stock rockets 30% on Eli Lilly takeover speculation

ABVX LLY

Jan 12, 2026, 5:03 AM EST - 4 months ago

Abivax Surges on Report Eli Lilly is Preparing $17.5 Billion Bid

ABVX LLY

Jan 12, 2026, 4:38 AM EST - 4 months ago

Abivax shares soar 23% as media report reignites M&A chatter

ABVX LLY

Jan 9, 2026, 6:54 AM EST - 4 months ago

A little-known biotech stock has become a prime takeover target after surging nearly 1,700% last year

ABVX LLY

Jan 7, 2026, 4:05 PM EST - 4 months ago

Abivax Provides 2026 Corporate Outlook

ABVX

Mon, 22 Dec 2025 19:09:18 -0500 - 4 months ago

Why Abivax Stock Was on Fire Today

Dec 18, 2025, 4:05 PM EST - 5 months ago

Abivax to be Added to Nasdaq Biotechnology Index

ABVX

Dec 17, 2025, 4:05 PM EST - 5 months ago

Abivax Announces Acceptance of 22 Abstracts Evaluating Obefazimod in Inflammatory Bowel Disease at ECCO 2026, Featuring an Oral Presentation on Preclinical Anti-Fibrotic Findings

ABVX

Dec 10, 2025, 12:42 PM EST - 5 months ago

What's Happening With French Biotech Abivax Stock On Wednesday?

ABVX

Dec 10, 2025, 5:52 AM EST - 5 months ago

French biotech Abivax's shares climb on Eli Lilly bid rumors

ABVX LLY

Tue, 09 Dec 2025 16:45:00 -0500 - 5 months ago

2 Under-the-Radar Stocks That Have Soared This Year

Nov 18, 2025, 12:59 PM EST - 6 months ago

6 Healthcare Stocks With Strong Upward Momentum

ABVX CAH ELAN GH MEDP WGS

Oct 6, 2025, 11:05 AM EDT - 7 months ago

Why Is Abivax Stock Trading Higher On Monday?

ABVX

Oct 6, 2025, 9:00 AM EDT - 7 months ago

ABIVAX Société Anonyme Transcript: The United European Gastroenterology (UEG) Congress UEG Week 2025

Oct 5, 2025, 11:00 AM EDT - 7 months ago

Abivax Announces Late-Breaking Presentation of 8-Week ABTECT Trial Results with Updated Safety Data

ABVX

Sep 29, 2025, 4:05 PM EDT - 7 months ago

Abivax Announces Acceptance of Additional Late-Breaking Abstract from the ABTECT Phase 3 Induction Trials to be Presented at 2025 United European Gastroenterology (UEG) Meeting

ABVX

Sep 23, 2025, 4:05 PM EDT - 8 months ago

Abivax Announces Presentation of Late-Breaking Abstract for Obefazimod from the ABTECT Phase 3 Induction Trials at 2025 United European Gastroenterology (UEG) Meeting

ABVX

Sep 12, 2025, 11:45 AM EDT - 8 months ago

Abivax to Join CAC Mid 60 and SBF 120 Indices Following Euronext Paris Annual Review

ABVX

Sep 8, 2025, 4:00 PM EDT - 8 months ago

Abivax Presents First Half 2025 Financial Results

ABVX

Aug 30, 2025, 5:30 AM EDT - 8 months ago

How Hedge Funds Won Big on an Obscure Drugmaker

ABVX

Jul 28, 2025, 4:15 PM EDT - 10 months ago

Abivax Announces Closing of $747.5 Million Public Offering

ABVX

Jul 25, 2025, 2:00 AM EDT - 10 months ago

Abivax Announces Full Exercise of Underwriters' Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $747.5M (€637.5M)

ABVX

Jul 24, 2025, 8:40 AM EDT - 10 months ago

Abivax announces trading resumption of its ordinary shares on Euronext Paris

ABVX

Jul 24, 2025, 8:40 AM EDT - 10 months ago

Abivax Announces Pricing of $650M (€554M) Public Offering of American Depositary Shares

ABVX

Jul 24, 2025, 1:30 AM EDT - 10 months ago

Abivax announces temporary trading halt of its ordinary shares on Euronext Paris

ABVX

Jul 23, 2025, 4:15 PM EDT - 10 months ago

Abivax Announces Launch of Public Offering

ABVX

Jun 11, 2025, 4:00 PM EDT - 11 months ago

Abivax Announces Results of its June 6, 2025 Annual General Meeting

ABVX

Jun 2, 2025, 4:00 PM EDT - 1 year ago

Abivax Presents First Quarter 2025 Financial Results

ABVX

Jun 2, 2025, 11:00 AM EDT - 1 year ago

Biotech Bull Case, ABVX International Interest, JNJ & LLY Options Trades

JNJ LLY ABVX

Apr 29, 2025, 4:05 PM EDT - 1 year ago

Abivax Announces Completion of Enrollment for the Phase 3 ABTECT Trials in Patients with Moderately to Severely Active Ulcerative Colitis

ABVX

Apr 22, 2025, 4:05 PM EDT - 1 year ago

Abivax Announces Annual General Meeting Details as Company Advances Toward Key 2025 Value-Driving Milestones

ABVX

Apr 22, 2025, 4:00 PM EDT - 1 year ago

Abivax Announces Appointment of Dominik Höchli, MD to Board of Directors

ABVX

Mar 26, 2025, 5:05 PM EDT - 1 year ago

Abivax publishes financial reports with the French and U.S. securities regulatory agencies

ABVX

Mar 24, 2025, 3:30 AM EDT - 1 year ago

Abivax Announces Full Year 2024 Financial Results

ABVX

Feb 21, 2025, 2:30 AM EST - 1 year ago

Abivax to Host Key Opinion Leader (KOL) Webcast on March 17, 2025

ABVX

Jan 28, 2025, 2:30 AM EST - 1 year ago

Abivax Publishes 2025 Financial Calendar

ABVX

Jan 23, 2025, 4:05 PM EST - 1 year ago

Abivax Announces Presentation of Seven Abstracts for Obefazimod in Ulcerative Colitis at 2025 European Crohn's and Colitis Organization 20th Annual Congress

ABVX

Jan 9, 2025, 11:35 AM EST - 1 year ago

Abivax Achieves Key Milestone in Phase 3 ABTECT Trial Enrollment

ABVX

Dec 23, 2024, 4:05 PM EST - 1 year ago

Abivax Announces a Change to the Composition of its Board of Directors

ABVX

Nov 19, 2024, 4:30 PM EST - 1 year ago

Abivax Establishes an At-the-Market (ATM) Program on Nasdaq

ABVX

Nov 14, 2024, 4:01 PM EST - 1 year ago

Abivax presents third quarter 2024 key financial information

ABVX

Nov 13, 2024, 4:01 PM EST - 1 year ago

Abivax Announces Former Prometheus COO, Mark Stenhouse, Appointed as Board Observer & Advisor to Abivax

ABVX

Oct 7, 2024, 4:01 PM EDT - 1 year ago

Abivax Congratulates Victor Ambros and Gary Ruvkun on Their Nobel Prize for the Discovery of microRNA and its Role in Post-Transcriptional Gene Regulation

ABVX

Oct 3, 2024, 4:01 PM EDT - 1 year ago

Abivax Announces First Patient Enrolled in ENHANCE-CD, the Phase 2b Trial of Obefazimod in Crohn's Disease

ABVX

Oct 3, 2024, 2:31 AM EDT - 1 year ago

Abivax Reports Positive Interim Efficacy and Safety Analysis of Once-Daily 25mg Obefazimod in Moderate to Severe Ulcerative Colitis Patients After 2-Years of Open-Label Maintenance

ABVX

Sep 26, 2024, 2:30 AM EDT - 1 year ago

Abivax to Present Three Abstracts for Obefazimod in Ulcerative Colitis at the UEG Week 2024

ABVX

Sep 25, 2024, 4:01 PM EDT - 1 year ago

Abivax Provides Update on Ulcerative Colitis (UC) Combination Therapy Program Strategy and Announces Early Preclinical Combination Data of Obefazimod and Etrasimod in Inflammatory Bowel Disease (IBD) Mouse Model

ABVX

Razgooz May. 8 at 11:16 PM

$ABVX monday buyout

0 · Reply

Jblack500 May. 8 at 3:59 PM

$ANIP $GILD $ELAN $ARWR $ABVX who bought the dip..I know I did...current pt is near 110 and will see pt increases on this q and guidance

0 · Reply

SayItToMeSantos May. 8 at 2:58 PM

$SLS Study the $ABVX chart of summer 2025. That's what SLS will do this year. 🤞 All the pieces getting put in place while we wait. Super

0 · Reply

Jblack500 May. 8 at 1:55 PM

$ANIP $GILD $ELAN $ARWR $ABVX anip pullback on these earnings is a gift and should be bought

0 · Reply

Jblack500 May. 8 at 11:59 AM

$ANIP $ABVX $ARWR $GILD $ELAN anip earnings were excellent

0 · Reply

Longi11 May. 8 at 10:22 AM

$ABVX THEY ARE ACQUIRED

2 · Reply

StockProph3t May. 7 at 11:09 PM

$ABVX MDG make retail happy

0 · Reply

CrispDry May. 7 at 5:11 AM

$ABVX anxiety is killing me

1 · Reply

Jblack500 May. 6 at 6:38 PM

1 · Reply

Razgooz May. 6 at 4:10 PM

$ABVX through technicals adding

0 · Reply

Jake_Meehof May. 6 at 2:58 PM

$ABVX FUCK SLS!

1 · Reply

55X_ROI_Q1_2026 May. 6 at 2:29 PM

$SLS Smart Money was accumulating $ABVX at $10 while the 'DIOTS were Selling 5m shares of $ABVX at $10 thinking they were good with 20% 50% .... the day before it jumped to $60.... and it Kept Climbing - from $5 and change to a High of $148.... Based on P3 Trial Results - in a smaller market with a Smaller TAM than GPS for AML Remission Maintenance.

1 · Reply

55X_ROI_Q1_2026 May. 6 at 2:24 PM

$SLS $ABVX Share Price will continue Climbing until it launches, the Positive P3 result is worth every nickel of $40B to Big Pharma. $5 Stock will be a $50 Stock the Instant the Phase 3 Results are announced... Will See $30 - $40 just on the 80th Event Announcement ... Could be any day.

1 · Reply

Longi11 May. 6 at 1:02 PM

$ABVX I can’t wait any longer I want to sell this!!

0 · Reply

Wongiiee May. 6 at 12:51 PM

$ABVX

0 · Reply

BanditQ May. 6 at 12:24 PM

$ABVX

0 · Reply

dutchiestocks May. 6 at 8:24 AM

$ABVX High volume EU trading this morning, love it. Think it will pass $130 with ease if this continues.

0 · Reply

55X_ROI_Q1_2026 May. 6 at 12:40 AM

$SLS Smart Money Moving into Position Knows the 80th Event PR Could be Announced Any Day Now. 5M $ABVX shares traded the DAY Before their P3 Results were announced - 5M shares Sold and 5M shares bought - at $10 the Day Before the Share Price Jumped to $60 - in an instant. Meanwhile just weeks prior barely 100k shares traded for $5 and change ... languishing ... The $ABVX Buyers down there at $5 Got an Instant 1,200% GAIN when the P3 News was announced. and it Kept Climbing to a High of $148 - from $5 to $148 / $270M to $14B Mcap all based on the Power of P3 Trial Data --- Like what is Now Coming for GPS.

1 · Reply

Razgooz May. 5 at 11:29 PM

$ABVX 220+

0 · Reply

Yimmiedd May. 5 at 10:48 PM

$ABVX will have $4.5k to add next Tuesday. Surely the company will exist next Tuesday 😉

1 · Reply

55X_ROI_Q1_2026 May. 5 at 7:35 PM

$SLS Funny 5M shares'ish traded the Day Before the P3 Results were announced - 5 m shares Sold and 5 m shares bought - at $10 the Day Before the Share Price Jumped to $60 - in an instant. Meanwhile just 2 weeks prior barely 100k shares traded for $5 and change ... languishing ... The $ABVX Buyers down there Saw an an Instant 1,200% GAIN when the P3 News was announced.

0 · Reply

Jblack500 May. 5 at 7:32 PM

@MaverikIT @No_Face_character @cynicaloptimist @IsabellaDC @BustaCapital @WAJeff Michelle Ross, stud biotech investor on CNBC right now giving the pump to $RVMD and $ROIV and she is still in $ABVX. i was in roivant for nice gain in the past. She is one of the best to get ideas from

2 · Reply

Market Cap	9.88B
Revenue (ttm)	0.00
Net Income (ttm)	-380.27M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	916,000
Avg Vol	971,676
Day's Range	N/A - N/A
Shares Out	79.29M
Stochastic %K	72%
Beta	0.84
Analysts	Strong Sell
Price Target	$150.83